戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n (hRTN(+/-)(/-)) but are deficient in mouse resistin.
2 tissues from adult rat hearts overexpressing resistin.
3 ng 12.1% and 8.5% of variance in circulating resistin.
4 /EBPbeta) expression vectors with or without resistin.
5 an articular chondrocytes were cultured with resistin.
6 al and high-molecular-weight adiponectin and resistin.
7          The RETN gene encodes the adipokine resistin.
8 eptor, also prevented the effects of central resistin.
9 due to reduced expression and circulation of resistin.
10 ate pituitaries expressed leptin/adiponectin/resistin.
11 may be transduced, in part, by its impact on resistin.
12 ormal T cell expressed and secreted PDGF and RESISTIN.
13 fold, angiotensinogen 3-fold, leptin 2-fold, resistin 4-fold, and adiponectin 4-fold; P<0.01 compared
14  experiments showed that pre-incubation with resistin (40 ng/ml) significantly impaired the ability o
15 ale + PVAT 97.3 +/- 0.9% vs. female + PVAT + resistin([40ng/ml]) 36.8 +/- 2.3%).
16 onectin concentrations, as well as 16% lower resistin, 41% lower CRP, 19% lower sE-selectin, and 24%
17 ximally adjusted model, each SD increment in resistin (7.45 ng/ml) was associated with a 26% increase
18                                              Resistin, a cysteine-rich adipocytokine, proposed as a l
19                             Plasma levels of resistin, a proinflammatory cytokine and uremic toxin, w
20                                              Resistin, a protein linked with inflammation and cardiom
21 d inflammation and suggest that hypothalamic resistin action can contribute to hyperglycemia in type
22  that bi-directional changes in hypothalamic resistin action have dramatic effects on GP and proinfla
23            Conversely, central antagonism of resistin action markedly diminished the ability of circu
24         Together, these results suggest that resistin action on NPY neurons is an important regulator
25               The proinflammatory leptin and resistin adipokines have been described as possible link
26  We compared serum concentrations of leptin, resistin, adiponectin, and visfatin in 167 RA patients a
27 al and circulating levels of adipocytokines (resistin, adiponectin, leptin, tumor necrosis factor [TN
28 ly improved by the simultaneous inclusion of resistin, adipsin, and total adiponectin (c-statistic: 0
29                                              Resistin, adipsin, and total adiponectin provided increm
30                      Higher plasma levels of resistin, adipsin, and total adiponectin were associated
31 roperties of 4 plasma adipocytokines, namely resistin, adipsin, leptin, and total adiponectin, with r
32 amined whether the human-specific variant of resistin affects neutrophil activation and the severity
33                                              Resistin also stimulated the activation of p70(S6K), a d
34                              Serum levels of resistin, an adipose tissue-derived adipokine, are incre
35 tion was assessed by measurement of secreted resistin, an azurophilic granule marker, and by determin
36              Growing evidence indicates that resistin-an obesity-related cytokine-is upregulated in b
37                                              Resistin and acetaminophen levels were comparable in bot
38  We tested the association of the adipokines resistin and adiponectin with incident heart failure.
39  mainly influenced the circulating levels of resistin and adiponectin, whereas both obesity and perio
40     The data further show that repression of resistin and angiotensinogen expression involves recruit
41 lso results in elevated circulating level of Resistin and development of hepatic steatosis.
42 of cytokine signaling-3 (Socs3), a target of resistin and hepcidin implicated in insulin resistance.
43 ship between inflammatory increases in human resistin and insulin resistance.
44 he role of three key adipokines-adiponectin, resistin and leptin-as potential predictors of response
45 ment of secreted azurophilic granule protein resistin and profiling of the secretome, using mass spec
46        Change in diet score was unrelated to resistin and several cytokines.
47 l growth factor, myeloperoxidase, prolactin, resistin and soluble tumor necrosis factor alpha recepto
48 asma GIP, GLP-1, glucose, insulin, glucagon, resistin, and acetaminophen levels.
49                    HPCs express adiponectin, resistin, and GLP-1, which become available to resident
50 PC-expressing adipokines (e.g., adiponectin, resistin, and glucagon-like peptide 1 [GLP-1]) were coun
51 romoters of white fat-specific genes such as resistin, and is abolished in the genetic absence of CtB
52                                              Resistin, and its closely related homologs, the resistin
53  fat transplants contained increased leptin, resistin, and monocyte chemoattractant protein-1 compare
54                Serum glucose, insulin, IL-6, resistin, and OVA-specific IgE levels were quantified.
55 n sensitivity and the levels of adiponectin, resistin, and serum RBP (RBP4).
56                   Expression of galectin-12, resistin, and SREBP-1 in SZ95 sebocytes was confirmed by
57 a caused hypoglycemia in mice lacking murine resistin, and this was attenuated in BAC-Retn mice.
58 4-h serum interleukin-6, C-reactive protein, resistin, and tumor necrosis factor-alpha levels by 3-29
59 nd serum adipocytokine (leptin, adiponectin, resistin, and visfatin) concentrations were determined i
60  necrosis factor-alpha, adiponectin, leptin, resistin, and vitamin D were measured at baseline.
61  fat genes ("visceral white"), including the resistin, angiotensinogen, and chemerin genes, in additi
62                                              Resistin antagonizes insulin action in mouse, making it
63                              Adiponectin and resistin are recently discovered adipokines that may pro
64 ignificantly less inflammatory cytokines and resistin as compared with MIF(+/+) mice and failed to de
65 n concentrations and lower concentrations of resistin, as well as biomarkers of inflammation, endothe
66 (24 h) with the following: 1) purified human resistin at various concentrations, with and without lov
67                                              Resistin, at physiological levels observed in human obes
68 erial artificial chromosome containing human resistin (BAC-Retn), whose expression was similar to tha
69 ciation kinetics of hRes subunits pointed to resistin being a molecular chaperone.
70 ory states, we generated mice lacking murine resistin but transgenic for a bacterial artificial chrom
71                                              Resistin by itself was able to induce acute kidney injur
72 A significant difference was observed in GCF resistin concentrations from group 1 versus group 2 (P =
73               Furthermore, recombinant human resistin could bind misfolded proteins only.
74                                         Only resistin (cut-off value 13.7 ng/ml) and IL-6 (cut-off va
75      Here we demonstrate that in normal mice resistin delivered in the lateral cerebral ventricle inc
76                                 Furthermore, resistin diminished statin-mediated up-regulation of the
77 ltration rate) using the lowest third of the resistin distribution as the referent, the hazard ratios
78 e other ancestry populations, we showed that resistin does not seem to increase insulin resistance an
79             Interestingly, we also show that resistin effects were abolished in TLR4 knockout mice an
80 sitize neutrophils to LPS stimulation, human resistin enhanced neutrophil extracellular trap formatio
81                                              Resistin expression in HPCs increased in pNAFLD and was
82 ubsequent western blot validation identified resistin expression to be increased approximately 2-fold
83                                           LV resistin expression was markedly elevated in POH, mildly
84 genes including tumor necrosis factor alpha, resistin, FABP4, and PPARgamma.
85 elationship between the CRD of PCSK9 and the resistin family is not observed in primary sequence comp
86 HF diet-induced elevations of plasma leptin, resistin, fed-state and fasting insulin and increased ex
87 lasma peptide YY (PYY), leptin, ghrelin, and resistin for all subjects.
88 d the expression of known adipogenic factors resistin, galectin-12, sterol response-element-binding p
89               To better understand how mouse resistin gene (Retn) expression is restricted to fat tis
90  two SNPs were significantly associated with resistin gene (RETN) mRNA levels in white blood cells fr
91 ited to the transcription loci and regulates resistin gene expression upon insulin stimulation.
92     In addition it causes IR, higher hepatic resistin gene expression, and up-regulation of hepatic i
93 ent study was initiated to determine whether resistin has additional roles in GIP-regulated adipocyte
94                                              Resistin has been associated with inflammation and risk
95                                              Resistin has been suggested to be involved in the develo
96                                              Resistin has diverse effects on gene expression in human
97  obesity, recent studies also suggested that resistin has proinflammatory properties.
98 roup box (HMGB)-1, B7 Homolog 1, S100A4, and resistin have been detected in tissues of dermatomyositi
99                      Because human and mouse resistin have distinct patterns of tissue distribution,
100 , plasminogen activator inhibitor-1 (PAI-1), resistin, hepatocyte growth factor, interleukin-6 (IL-6)
101 ed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples.
102 wing a distinct structural similarity to the resistin homotrimer, a small cytokine associated with ob
103                                              Resistin (HR, 1.88; 95% confidence interval [CI], 1.16-3
104               We earlier reported that human resistin (hRes), a trimer, was resistant to heat and ure
105                                        Human resistin (hRetn) is an immune cell-derived protein that
106 resistin mice that exclusively express human resistin (hRTN(+/-)(/-)) but are deficient in mouse resi
107  i) serum hormone concentrations (leptin and resistin), ii) adipose tissue mRNA expression of inflamm
108                                  The hormone resistin impairs the response to insulin in liver and ot
109 ted with circulating levels of the adipokine resistin in a lipolysis-dependent manner.
110 lating higher molecular weight structures of resistin in both rodent and human serum.
111              The findings suggest a role for resistin in human disease and a novel pathway to heart f
112 d by antibody-immunoprecipitation removal of resistin in human serum, which decreased serum stimulati
113                     However, the function of resistin in humans is enigmatic.
114        Emerging evidence suggests a role for resistin in inflammation and vascular dysfunction, which
115   The quantitatively important role of human resistin in LDLR expression was demonstrated by antibody
116     These findings indicate a novel role for resistin in mediating sex-dependent vascular function in
117  a central role in the genetic regulation of resistin in monocytes along with promoter methylation.
118 or galectin-12 and SREBP-1 in the nuclei and resistin in the cytoplasm of basal sebocytes, and stearo
119 e results strongly support the role of human resistin in the development of insulin resistance in inf
120 udy is to estimate and compare the levels of resistin in the gingival crevicular fluid (GCF) in healt
121 learly identify TLR4 as the binding site for resistin in the hypothalamus and bring new insight into
122 p-regulation of the LDLR by 60%, implicating resistin in the relative ineffectiveness of statins in s
123  an altered adipokine response (i.e., higher resistin increase and an adiponectin fall), and hepatocy
124 and did not alter LH/FSH/TSH-release; and 3) resistin increased ACTH-release and did not alter PRL/LH
125 ally, we report that intracerebroventricular resistin increased plasma FGF21 levels and downregulated
126                                 Furthermore, resistin increased serine phosphorylation of insulin rec
127  normal-weight bone explant with recombinant resistin increased the Type I collagen alpha1/alpha2 rat
128 n of primary OA osteoblasts with recombinant resistin increased Wnt signalling activation, osteoblast
129 zation analyses did not provide evidence for resistin increasing insulin resistance, body mass index,
130                                      Central resistin induced expression of proinflammatory cytokines
131  to elucidate the mechanisms associated with resistin-induced cardiac hypertrophy and myocardial insu
132 ith rapamycin or mTOR siRNA attenuated these resistin-induced changes.
133 trally mediated mechanisms partially control resistin-induced expression of TNF-alpha, IL-6, and SOCS
134 ranscriptional up-regulation are involved in resistin-induced gene expression in human chondrocytes.
135 ht into the molecular mechanisms involved in resistin-induced inflammation and insulin resistance in
136 NF-kappaB and C/EBPbeta were involved in the resistin-induced up-regulation.
137                  These data demonstrate that resistin induces cardiac hypertrophy and myocardial insu
138 We show that chronic intracerebroventricular resistin infusion downregulated both hypothalamic and he
139 In the current study, we report that chronic resistin infusion in the lateral cerebral ventricle of n
140                        In agreement, central resistin inhibited Akt phosphorylation and increased the
141               A key mechanism by which human resistin inhibited LDLR levels was by increased cellular
142                                              Resistin inhibited neutrophilic-differentiated NB4 cell
143                          Expression of human resistin inhibited the activation of AMP-activated prote
144                              Furthermore, rm-resistin-injected normal chow-fed mice showed upregulate
145 receptors (TLR)2, TLR4, and TLR9, as well as resistin, interleukins (IL)-1beta, IL-4, and IL-6 and ox
146   These findings provide clear evidence that resistin is a clinically relevant endogenous ligand for
147 These results reveal for the first time that resistin is a highly attractive therapeutic target in am
148                                              Resistin is a key cytokine associated with metabolic and
149                                              Resistin is a polypeptide hormone that was reported to b
150 rease in resistin was also observed; because resistin is a potent pro-inflammatory compound, this dec
151                                              Resistin is associated with local and systemic inflammat
152                    We recently reported that resistin is expressed in diabetic hearts and promotes ca
153                                              Resistin is greatly elevated during acute kidney injury,
154                                    In vitro, resistin is induced by angiotensin II and induces CTGF i
155 tes, independent of body mass index, whereas resistin is not.
156 at the human homolog of RELMalpha, human (h) resistin, is upregulated in macrophage-like inflammatory
157 ne in this region is the structural gene for resistin, itself.
158 onectin, an insulin-sensitizing hormone, and resistin, known to promote insulin resistance, constitut
159 luding tumor necrosis factor, interleukin-6, resistin, leptin, and monocyte chemotactic protein-1, an
160 ' side of RETN were strongly associated with resistin levels (all minor alleles associated with highe
161 of hypertension, but the association between resistin levels and incident hypertension is unknown.
162 us acute kidney injury still showed elevated resistin levels and inhibited neutrophilic-differentiate
163   We examined the association between plasma resistin levels and the risk for incident hypertension a
164                                              Resistin levels are increased in CP and T2DM.
165 riant as likely causal affecting circulating resistin levels as a cis-eQTL increasing RETN expression
166 ) and the NDST4 gene (4q25), associated with resistin levels at a genome-wide significant level, best
167 s to infer genetic causality for circulating resistin levels by performing genome-wide association st
168                               Only admission resistin levels could serve as an early predictor for SA
169   In this study, we observed that high serum resistin levels in breast cancer patients positively cor
170 -wide association (GWA) study on circulating resistin levels in individuals of European ancestry draw
171  After adjustment for potential confounders, resistin levels in the highest tertile conferred a 75% h
172                      In stratified analysis, resistin levels in the highest tertile significantly inc
173                 In conclusion, higher plasma resistin levels independently associate with an increase
174                                   Hence, GCF resistin levels may be considered as a potential inflamm
175 atin; and 2) obese human serum with elevated resistin levels or serum from which resistin was removed
176  all the samples were analyzed together, GCF resistin levels positively correlated with GI, PD, PI, R
177  association of SNP -420C/G (rs1862513) with resistin levels remained significant (P = 0.0009) but wi
178 for these biomarkers and C-reactive protein, resistin levels remained significantly associated with i
179 lammatory and endothelial biomarkers, plasma resistin levels significantly correlated with IL-6, solu
180   GCF (4 muL) was collected and analyzed for resistin levels using an enzyme-linked immunosorbent ass
181 ariate model without body mass index, higher resistin levels were associated with a higher risk for d
182                                    In serum, resistin levels were higher whereas adiponectin levels w
183 irculating insulin, adiponectin, leptin, and resistin levels were measured in 36 patients with advanc
184               Additional variants regulating resistin levels were upstream of RETN with genes PCP2, S
185 We found that BAC-Retn mice have circulating resistin levels within the normal human range, and simil
186 in the 3' region of RETN are associated with resistin levels, and one of them is also associated with
187  Framingham Offspring Study participants for resistin levels, glycemic phenotypes, and incident diabe
188  in RETN and tested associations with plasma resistin levels, risk of diabetes, and glycemic traits.
189             Associations of RETN with plasma resistin levels, type 2 diabetes, and related metabolic
190 e for most of the variability in circulating resistin levels.
191 be involved in the regulation of circulating resistin levels.
192  lipopolysaccharide markedly increased serum resistin levels.
193  (which have elevated levels of the cytokine resistin-like beta, RELMbeta, and are extremely sensitiv
194  sensitivity and a marked reduction in serum Resistin-like molecule (RELM) alpha, a multifunctional c
195 of Arginase 1, chitinase-like molecules, and resistin-like molecule (RELM) alpha/FIZZ1; however, the
196 differentiate into goblet cells that secrete resistin-like molecule (RELM) beta.
197 in inflammatory zone (FIZZ) 2, also known as resistin-like molecule (RELM)-beta, belongs to a novel c
198                                              Resistin-like molecule (RELM)alpha belongs to a family o
199                                              Resistin-like molecule alpha (Relm-alpha) is a secreted
200                           Here, we show that resistin-like molecule alpha (RELMalpha), a small secret
201 ulomatous inflammation, increased numbers of resistin-like molecule alpha(+) cells, and enhanced coll
202 so known as found in inflammatory zone 1 and resistin-like molecule alpha, belongs to a novel class o
203 that expressed a smooth muscle cell mitogen, resistin-like molecule alpha, but surprisingly, there wa
204  protein product of the most promising gene, resistin-like molecule alpha, demonstrated a significant
205                      Goblet cell numbers and resistin-like molecule beta (RELM-beta) expression were
206 3 production in IL-33-deficient mice impairs resistin-like molecule beta (RELMbeta) expression and eo
207     The secreted goblet cell-derived protein resistin-like molecule beta (RELMbeta) has been implicat
208                           Here, we show that resistin-like molecule beta (RELMbeta) is a bactericidal
209                                              Resistin-like molecule beta (RELMbeta) is a goblet cell-
210          Basal and DSS-induced production of resistin-like molecule beta (RELMbeta) was substantially
211 ed expression of the antihelminthic proteins resistin-like molecule beta and mucin 5ac.
212 increase in secretion of goblet cell-derived resistin-like molecule beta into the intestinal lumen.
213                                              Resistin-like molecule beta is important in mucosal defe
214                                  In rodents, resistin-like molecule-alpha (RELMalpha, also known as H
215                  Moreover, the expression of resistin-like molecule-alpha, a target of IL-13 signalin
216 und in inflammatory zone 1 (FIZZ1/Retnla), a resistin-like molecule.
217                                              Resistin-like molecules (RELMs) are highly expressed fol
218 istin, and its closely related homologs, the resistin-like molecules (RELMs) have been implicated in
219 ore, HIF2alpha induced the expression of the resistin-like molecules alpha and beta (RELMalpha and be
220            Although adipocyte-derived murine resistin links insulin resistance to obesity, the role o
221 in, insulin resistance, leptin, adiponectin, resistin, liver function enzymes, fetuin-A, body composi
222             Upon STAT3 silencing, leptin and resistin lost their ability to activate PCSK9.
223          Plasma tumor necrosis factor-alpha, resistin, macrophage chemoattractant protein-1, and adip
224                                  Thus, human resistin may link insulin resistance to inflammatory dis
225 log deleted on chromosome ten) expression by resistin may mediate the inhibitory effects.
226               Our results suggest that human resistin may play an important contributory role in enha
227 e tissue, including leptin, adiponectin, and resistin, may influence osteoarthritis though direct joi
228 e of the molecular regulators of leptin- and resistin-mediated transcriptional induction of PCSK9.
229  In LPS-induced acute lung injury, humanized resistin mice demonstrated enhanced production of proinf
230 , experiments were performed using humanized resistin mice that exclusively express human resistin (h
231             To investigate the role of human resistin on glucose homeostasis in inflammatory states,
232                       The effects of central resistin on glucose production as well as hepatic expres
233 t we believe to be a novel site of action of resistin on GP and inflammation and suggest that hypotha
234                                The effect of resistin on primary OA osteoblasts was determined by ana
235                       The infusion of either resistin or an active cysteine mutant in the third cereb
236 istrated with recombinant mouse resistin (rm-resistin), or exposed to media from Lmo4-overexpressed 3
237 3), lower serum IL-(P = 0.0022), lower serum resistin (P = 0.0043), lower serum OVA-specific IgE (P =
238 atin (P = 0.06), adiponectin (P = 0.55), and resistin (P = 0.98) showed no association with the HOMA-
239 is study, our goal was to determine if human resistin plays a role in regulating the uptake of athero
240 lin resistance to obesity, the role of human resistin, predominantly expressed in mononuclear cells a
241                                              Resistin promotes both inflammation and insulin resistan
242        Here, we investigated whether central resistin promotes insulin resistance through the impairm
243                        Additionally, central resistin promotes the activation of the serine kinases J
244 We also found evidence for a QTL influencing resistin protein levels (LOD score 5.3) on chromosome 14
245                                 However, the resistin receptor and the molecular mechanisms mediating
246  did not affect the expression of leptin and resistin receptors or that of PCSK9.
247 NP rs13144478 with NDST4 gene expression and resistin-related disease.
248                          Marked variation in resistin release and the neutrophil secretome profile we
249  newly defined family of proteins, including resistin, Relm-beta, and Relm-gamma.
250 ogenic factor (HIMF) is a member of the FIZZ/resistin/RELM family of proteins that we have shown to h
251                                       A high resistin response was triggered exclusively by SpeB-nega
252 centrations of TNF-alpha, IL-6, adiponectin, resistin, retinol binding protein-4, or intraabdominal f
253 ha, IL-6, high-molecular-weight adiponectin, resistin, retinol binding protein-4, or intraabdominal o
254 was positively associated with expression of resistin (RETN) and negatively associated with expressio
255    Unlike expression of Retn in mouse, human resistin (RETN) is expressed primarily in macrophages.
256  chromosome 19p13 affecting the abundance of resistin (RETN) mRNA in the omental adipose tissue of ba
257  Rhox5-regulated genes are insulin 2 (Ins2), resistin (Retn), and adiponectin (Adipoq), all of which
258                             In addition, the resistin-rising allele of the TYW3/CRYZ SNP rs3931020, b
259 tocytes administrated with recombinant mouse resistin (rm-resistin), or exposed to media from Lmo4-ov
260 tro adipogenesis, transcription of Retn, and resistin secretion in 3T3-L1 cells.
261 ur results suggest a regulatory role of Lmo4-resistin signaling in weight cycling, indicating a cross
262 he interplay between adiponectin, FGF21, and resistin signaling pathways during the onset of insulin
263 eukin-8, monocyte chemoattractant protein-1, resistin, soluble interleukin-1 receptor I, soluble inte
264 alysis showed the expression of galectin-12, resistin, SREBP-1, and stearoyl-CoA desaturase mRNAs in
265                                   Leptin and resistin stimulated GH-release, a response that was bloc
266                                  Circulating resistin stimulates endogenous glucose production (GP).
267 ted that levels of the adipokines leptin and resistin, the inflammatory marker myeloperoxidase (MPO),
268 protein metabolism, is induced by leptin and resistin through the involvement of the inflammatory pat
269 n resistance onset orchestrated by a central resistin-TLR4 pathway that impairs adiponectin signaling
270 rkedly diminished the ability of circulating resistin to enhance GP.
271                In addition to the ability of resistin to sensitize neutrophils to LPS stimulation, hu
272 ime, to our knowledge, the direct binding of resistin to Toll-like receptor (TLR) 4 receptors in the
273                                              Resistin-treated human articular chondrocytes increased
274                                              Resistin treatment also decreased plasma adiponectin lev
275                                      Central resistin treatment inhibited insulin-dependent phosphory
276  transcription inhibitor actinomycin D after resistin treatment or with the NF-kappaB inhibitor IKK-N
277 d in Retn(+/-) and Retn(-/-) adipocytes, but resistin treatment rescued LPL responsiveness to GIP.
278  with the NF-kappaB inhibitor IKK-NBD before resistin treatment.
279                   In HepG2 cells, leptin and resistin up-regulated PCSK9 gene and protein expression,
280                            Overexpression of resistin using adenoviral vector in neonatal rat ventric
281         Here, we show that recombinant human resistin was able to protect the heat-labile enzymes cit
282               A ketamine-induced decrease in resistin was also observed; because resistin is a potent
283                          Central infusion of resistin was associated with neuronal activation in the
284                             In 3T3-L1 cells, resistin was demonstrated to be a key mediator of GIP st
285                                              Resistin was detected in the GCF of all patients.
286                       The RELM family member Resistin was expressed in human skin, was induced by vit
287                                              Resistin was found to promote epithelial-mesenchymal tra
288                   The serum concentration of resistin was higher in overweight/obese OA patients, com
289                                              Resistin was initially defined based on its insulin resi
290 rage, TGF-beta was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared wit
291                                     Although resistin was recently found to modulate insulin resistan
292 elevated resistin levels or serum from which resistin was removed via antibody-immunoprecipitation.
293                                       Plasma resistin was significantly higher in patients with septi
294            Another RELM family member, human resistin, was also bactericidal, suggesting that bacteri
295      Increased circulating concentrations of resistin were associated with incident heart failure, ev
296 nsity lipoprotein-cholesterol (LDL-CHL), and resistin were higher in the raspberry group.
297 iation studies and fine-mapping analyses for resistin were performed in 5621 African-ancestry individ
298                            PYY, ghrelin, and resistin were significantly elevated in cases and fell d
299 several adipokines, including Retn (encoding resistin), were found altered by weight cycling.
300 flammatory proteins CCL3 and CCL4 as well as resistin, which augments monocyte-endothelial adhesion.

 
Page Top